New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report.
Clin Case Rep
; 10(10): e6473, 2022 Oct.
Article
in English
| MEDLINE | ID: covidwho-2127617
ABSTRACT
Adverse reactions, including the onset of diabetes, after coronavirus disease 2019 (COVID-19) vaccination have been reported. Herein, we report a case of a man who developed anti-glutamic acid decarboxylase (GAD) antibody-positive fulminant type 1 diabetes 15 weeks after COVID-19 vaccination, atypical of the previously reported anti-GAD antibody-negative cases.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Vaccines
Language:
English
Journal:
Clin Case Rep
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS